Analyst forecasts YoY quarterly growth for Coloplast following virus year

Improved market conditions owing to increased patient access in the wake of societal reopenings should, says Denmark's Sydbank, result in Coloplast reporting growth on Wednesday, when the Danish medical tech firm presents its Q3 interim report for fiscal 2021.

Photo: Coloplast / PR

Upon presenting its third-quarter statement for staggered fiscal year 2020-'21, Danish medical technology company Coloplast is expected to announce growth driven by improved market conditions tied to improved patient access following societies opening back up from pandemic lockdowns, says Senior Analyst Søren Løntoft Hansen from Denmark's Sydbank.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs